Alzamend Neuro, Inc. (ALZN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.99
Day's range
$2.25

Alzamend Neuro Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 45.68 K $48.42 K   66.07% 1.20%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 21.02 K $22.28 K   100.00% 0.55%
MORGAN STANLEY 05/15/2026 18.00 K $19.08 K   0.00% 0.47%
CLEARSTEAD ADVISORS, LLC 05/06/2026 10.00 K $10.60 K   0.00% 0.26%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 6.18 K $6.56 K   197.16% 0.16%
CITIGROUP INC 05/11/2026 5.23 K $5.55 K   100.00% 0.14%
UBS GROUP AG 05/05/2026 4.50 K $4.77 K   -81.67% 0.12%
05/15/2026 4.40 K $4.66 K   100.00% 0.12%
BLACKROCK, INC. 05/13/2026 437 $463   0.00% 0.01%
SBI SECURITIES CO., LTD. 04/28/2026 22 $23   0.00% 0.00%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 05/11/2026 4 $4   100.00% 0.00%
HARBOR INVESTMENT ADVISORY, LLC 04/23/2026 1 $1   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/18/2026 0 $0   -100.00% 0.00%
DRW SECURITIES, LLC 05/13/2026 0 $0   -100.00% 0.00%
VIRTU FINANCIAL LLC 05/14/2026 0 $0   -100.00% 0.00%
XTX TOPCO LTD 05/15/2026 0 $0   -100.00% 0.00%

Alzamend Neuro Inc institutional Ownership - FAQ's

During the previous two years, 19 institutional investors and hedge funds held shares of Alzamend Neuro Inc. The most heavily invested institutionals were:

GEODE CAPITAL MANAGEMENT, LLC: 45,680

VANGUARD FIDUCIARY TRUST CO: 21,020

MORGAN STANLEY: 18,000

Clearstead Advisors, LLC: 10,000

Tower Research Capital LLC (TRC): 6,184

CITIGROUP INC: 5,231

3.04% of Alzamend Neuro Inc stock is owned by institutional investors.

Institutional investors have bought a total of 172.51 K shares in the last 24 months. This purchase volume represents approximately $362.27 K in transactions.